Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biologics. Although there is consensus that these therapies reduce the frequency of relapses, their relative benefit in delaying new relapses or disability worsening remains unclear due to the limited number of direct comparison trials.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis / Tramacere, Irene; DEL GIOVANE, Cinzia; Salanti, Georgia; D'Amico, Roberto; Filippini, Graziella. - In: COCHRANE DATABASE OF SYSTEMATIC REVIEWS. - ISSN 1469-493X. - 2015:9(2015), pp. 1-152. [10.1002/14651858.CD011381.pub2]
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis
DEL GIOVANE, Cinzia;D'AMICO, Roberto;
2015
Abstract
Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biologics. Although there is consensus that these therapies reduce the frequency of relapses, their relative benefit in delaying new relapses or disability worsening remains unclear due to the limited number of direct comparison trials.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Tramacere_et_al-2015-The_Cochrane_Library.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
4.01 MB
Formato
Adobe PDF
|
4.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
